Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation.

Lamb DJ, Puxeddu E, Malik N, Stenoien DL, Nigam R, Saleh GY, Mancini M, Weigel NL, Marcelli M.

J Androl. 2003 Mar-Apr;24(2):215-25.

2.

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP.

Cancer Res. 1997 Jan 15;57(2):314-9.

3.

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.

Suzuki H, Akakura K, Komiya A, Aida S, Akimoto S, Shimazaki J.

Prostate. 1996 Sep;29(3):153-8.

PMID:
8827083
4.
5.

Androgen receptor mutations in prostate cancer.

Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L, Zhao Y, DiConcini D, Puxeddu E, Esen A, Eastham J, Weigel NL, Lamb DJ.

Cancer Res. 2000 Feb 15;60(4):944-9.

6.

Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.

Thompson J, Hyytinen ER, Haapala K, Rantala I, Helin HJ, Jänne OA, Palvimo JJ, Koivisto PA.

Lab Invest. 2003 Dec;83(12):1709-13.

PMID:
14691288
7.

Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy.

Culig Z, Klocker H, Bartsch G, Hobisch A.

Am J Pharmacogenomics. 2001;1(4):241-9. Review.

PMID:
12083956
8.

Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics.

Chen G, Wang X, Zhang S, Lu Y, Sun Y, Zhang J, Li Z, Lu J.

Prostate. 2005 Jun 1;63(4):395-406.

PMID:
15617028
9.
10.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
11.

Expression and somatic mutation on androgen receptor gene in prostate cancer.

Segawa N, Nakamura M, Shan L, Utsunomiya H, Nakamura Y, Mori I, Katsuoka Y, Kakudo K.

Int J Urol. 2002 Oct;9(10):545-53.

12.

Androgen receptor gene mutations in hormone-refractory prostate cancer.

Wallén MJ, Linja M, Kaartinen K, Schleutker J, Visakorpi T.

J Pathol. 1999 Dec;189(4):559-63.

PMID:
10629558
13.

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor.

Mizokami A, Koh E, Fujita H, Maeda Y, Egawa M, Koshida K, Honma S, Keller ET, Namiki M.

Cancer Res. 2004 Jan 15;64(2):765-71.

14.

Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis.

Evans BA, Harper ME, Daniells CE, Watts CE, Matenhelia S, Green J, Griffiths K.

Prostate. 1996 Mar;28(3):162-71.

PMID:
8628719
15.

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP.

J Cell Biochem. 2004 Feb 15;91(3):483-90. Review.

PMID:
14755679
16.

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.

Cancer Res. 2004 Aug 1;64(15):5489-95.

17.

Hypoxia increases androgen receptor activity in prostate cancer cells.

Park SY, Kim YJ, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY, Park YM.

Cancer Res. 2006 May 15;66(10):5121-9.

18.

Genetic alterations of androgen receptor gene in Japanese human prostate cancer.

Watanabe M, Ushijima T, Shiraishi T, Yatani R, Shimazaki J, Kotake T, Sugimura T, Nagao M.

Jpn J Clin Oncol. 1997 Dec;27(6):389-93.

19.

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.

Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S.

Cancer Res. 1994 Jun 1;54(11):2861-4.

20.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

Items per page

Supplemental Content

Support Center